Skip to main content
Download PDF

Influenza vaccination knowledge, attitudes, and practices among Tunisian elderly with chronic diseases

BMC Geriatrics volume 21, Article number: 700 (2021) Cite this article

Abstract

Background

Generally, seasonal influenza does not cause severe infection in healthy adults, but for the elderly, an infection can pose a serious health concern. Although several measures can help prevent influenza, vaccination is considered the most effective. This study aimed to assess influenza vaccine uptake among elderly with chronic diseases in Tunisia during the 2018–2019 influenza season, and to identify knowledge, attitudes and barriers associated with influenza vaccine uptake.

Methods

During influenza season of 2018–2019, we conducted a national cross-sectional study among elderly with chronic disease who were attending primary and secondary health care facilities in Tunisia. We collected data regarding practices, general knowledge and attitudes related to influenza and influenza vaccine, using a standardized questionnaire. A multivariate analysis by logistic regression was performed to assess the factors influencing willingness to receive influenza vaccine.

Results

Among the 1191 surveyed elderly, 19.4% (95%CI 14.1–21.9) were vaccinated during the 2018–2019 influenza season and 64.7% (61.9–67.3) expressed willingness to be vaccinated in the next season regardless of vaccination status in the 2018–2019 season. Previous vaccination in the 2018–2019 influenza season was the most significantly associated factor with willingness to receive influenza vaccine (adjusted OR = 16.5 [3.7–72.4]). Significant associations were also observed between knowledge of influenza severity for the elderly as well as for those with chronic diseases and willingness to be vaccinated (p < 0.01). Likewise, participants who were convinced by flu vaccine effectiveness and those who were not concerned about vaccine side effects were more likely to be vaccinated (p < 0.001). The main reason that may lead to vaccine acceptance was a doctor’s recommendation (41.1%), while the two main reasons that may lead to vaccine refusal were concerns about side effects (71.5%) and a belief that vaccine was ineffective in averting influenza illness (33.9%). Doctors were the most trusted source for information about influenza vaccine (91.5%).

Conclusion

Our study revealed low influenza vaccination coverage among Tunisian elderly with chronic diseases believed to be at higher risk for severe acute respiratory infections and death if infected with influenza. Treating physicians’ role in promoting influenza vaccination in this high-risk group seems to be crucial.

Peer Review reports

Introduction

Seasonal influenza is an infection of the airways caused by various influenza viral strains that annually undergo antigenic variations [1, 2]. This illness has a significant impact on both individuals and societies, and is responsible for a considerable economic burden in terms of treatment and hospitalizations [3, 4]. The World Health Organization (WHO) estimates that influenza infects about 5–15% of the population annually. The estimated annual global burden of influenza is nearly 3 to 5 million cases of severe disease, with a death toll ranging from 290,000 and 650,000 persons [5]. Generally, seasonal influenza does not cause severe infection in healthy adults, but for the elderly, an infection can pose a serious health concern [6]. The severity of influenza among the elderly is increased by the higher prevalence of comorbidities among this age group [6].

Although several measures can help prevent influenza, vaccination is considered the most effective [7]. Thus, in 2003, the World Health Assembly (WHA) urged all its Member States to implement strategies in order to increase influenza vaccination coverage of all high-risk individuals, including the elderly and those with underlying diseases, with the goal of reaching a minimum of 75% vaccination coverage by 2010 [4, 8]. Many countries have already implemented policies promoting influenza vaccination for high-risk groups, especially in the older populations [3, 9]. However, vaccine uptake for aging populations still remain below the WHO recommendations, even in developed countries [3]. Vaccine hesitancy, defined as the delay in vaccine acceptance or refusal regardless of vaccine availability [10], was found to have a detrimental impact on vaccine uptake [11]. Some factors influencing vaccine hesitancy were identified in previous studies [12, 13] such as concerns about vaccine efficacy and safety, physician-patient relationship and media environment.

In Tunisia, influenza vaccine is available in public health care facilities and free of charge for elderly patients under practitioners’ prescription. Unfortunately, record of the number of administered doses is not done systematically.

Periodic surveys to estimate the uptake rates of seasonal influenza vaccine could help to monitor success of national vaccination programs, to provide important information on the number of vaccine doses administered, rather than simply purchased, and to assess the degree of vaccination awareness in the surveyed population [14, 15]. Identifying factors associated with influenza vaccination behaviors among older persons may help to better design interventions to improve vaccine coverage [16]. This study aimed to evaluate influenza vaccine uptake in elderly persons with chronic disease(s) in Tunisia during the 2018–2019 influenza season, and to describe their knowledge and attitudes towards influenza and influenza vaccination. Our ultimate objective is to identify predictors of seasonal influenza vaccine uptake and related barriers in order to reduce the burden of influenza among this high risk group.

Methods

Study design

A cross-sectional study was conducted among elderly persons with chronic disease(s), between March and June 2019, who were attending primary and secondary heath care facilities.

Study population

The study population included: persons aged 60 years and over who sought care at public primary health centers, regional hospitals, or district hospitals, and who had at least one of the following chronic diseases/conditions: respiratory disease (chronic obstructive pulmonary diseases including asthma or other chronic pulmonary diseases); cardiac disease; diabetes; chronic renal failure requiring dialysis; cirrhosis; morbid obesity; and immunocompromising conditions (including patients undergoing chemotherapy or chronic corticosteroid therapy, and transplant patients taking immunosuppressive drugs). We conducted our study among this population since they represent a priority target group for influenza vaccination in Tunisia compared to healthy elderly. Individuals who did not provide written informed consent and those with cognitive disorders were not included in this survey.

Sample size and sampling procedure

In order to collect a representative sample of the target population, we estimated the sample size using Slovin’s formula. We took into consideration an expected size of elderly persons with chronic diseases (across both primary and secondary health centers) of between 10,000 and 100,000, a precision of 0.05, a design effect of 2.5, and a non-response rate equal to 20% leading to a sample size of ≈ 1200 individuals. We choose a self-weighted two-stage sampling scheme to ensure geographic representativeness at the country level. First a stratified sampling was performed based on the three Tunisian regions (North, Center and South). Eight out of the 24 Tunisian governorates were randomly selected: four in the north (Ariana, Ben Arous, Bizerte, Siliana), three in the center (Kairouan, Mahdia, Sousse), and one in the south (Gafsa). Following this, we proceed in each gouvernorate to selection by simple random sampling of health care facilities offering a consultation for persons with chronic diseases. Since the study was carried out on working days and that the days of consultation for chronic disease patients differ according to the health care centers; the selection of centers was made as the survey evolved. Every day a random sampling of one facility from the list of the health care centers offering consultation to chronically ill patients that day was performed. Each center already selected will no longer be selected afterwards. The recruitment of eligible persons was stopped after the achievement of the target sample size.

It should be noted that the calculated sample size was distributed according to the repartition of Tunisian elderly between the three Tunisian regions, to the weight of each governorate in the corresponding region and to the weight of the area of residence in each of the selected governorates.

Data collection

All illegible patients who were present during the visits of investigators to the selected healthcare facilities were approached to participate in the survey and informed about the aims of the study and the anonymity of participants. Those who accepted to participate signed an informed consent. A face to face standardized questionnaire was administered in Arabic to participants by trained investigators (medical doctors and paramedics).

The questionnaire was composed of three sections (Additional file 1). The first one included questions about participant’s medical history. The second contained questions related to practices, general knowledge and attitudes regarding influenza and influenza vaccine. Open ended questions were used to assess reasons of influenza vaccination acceptance and refusal, in addition to trusted sources of information about influenza vaccine. General statements regarding influenza and influenza vaccine were assessed using a 5-point Likert type items (1: Strongly Agree, 2: Agree, 3: Neutral, 4: Disagree, 5: Strongly Disagree). Before the beginning of the study, a meeting was conducted with all field investigators to assess the face to face validity of the questionnaire mainly questions wording and appropriateness of the survey instrument and to train investigators. To evaluate the understanding of questions, a pilot study was conducted in a primary health care facility in the governorate of Manouba which is located in Northern Tunisia but not selected in our survey. Thirty elderly with chronic diseases were interviewed during the pilot study. Collected data were not included in the final analysis.

In the present study, respondents did not receive any gift or monetary compensation for their participation.

Data analysis

Statistical analysis included a descriptive analysis where qualitative variables were summarized as numbers and percentages. The relationship between willingness to receive influenza vaccine and each of the explanatory categorical variables was determined by Fisher exact χ2 test and crude odds ratios (COR). Independent variables with a p-value ≤0.25 in the bivariate analysis were introduced in the multivariate model using a backward stepwise logistic regression. To measure the strength of association between explanatory variables and willingness to receive the vaccine and control for potential effect modifiers, adjusted odds ratios (AOR) were estimated by multivariate analyses. Missing and “I don’t know” or “I don’t remember” responses were excluded from these analyses. Comparisons of attitudes and general statements regarding influenza and influenza vaccine were performed by Fisher exact χ2 test between participants who wanted to receive the vaccine and those who refused to be vaccinated. For all analyses, two-tailed tests were used and a p-value ≤0.05 was considered significant.

Results

The study was conducted in 100 health care facilities: 47 in Northern Tunisia, 42 in the Center and 11 in the South. Overall, 1318 elderly persons with chronic diseases were approached to participate to the survey. Among them 1235 accepted to participate to the survey and were interviewed, giving a response rate of 93.7%. Only 1191 questionnaire were considered eligible for analysis. The 44 excluded forms were either missing important data or related to individuals non-complying with the inclusion criteria (some respondents were under 60 years of age or had isolated high blood pressure).

Nearly two-thirds of the participants were female and from urban areas. The age of participants ranged from 60 to 99 years; over half were aged 60–69. About 87% of patients had a primary school level education or less, and less than 4% of participants are still working (Table 1). Over 80% of participants were diabetic, and one-quarter had heart disease (Table 1).

Table 1 Main characteristics of participants
Full size table

Among respondents, 70.1% [67.4–72.9] were aware about the existence of a vaccine against influenza. Over one-third of participants (34.8% [32.2–37.6]) took the influenza vaccine at least once in the past and 19.4% [17.1–21.9] received this vaccine during the 2018–2019 influenza season, while 64.7% [61.9–67.3] of surveyed persons expressed their willingness to be vaccinated (Table 1).

Compared to participants who refused vaccination, persons who were willing to receive influenza vaccine the next season were more convinced that influenza was more dangerous for elderly persons (88.5% vs. 77.3%, p < 0.001) and for persons with chronic diseases (88.4% vs. 81.0%, p = 0.004) (Table 2). Participants willing to receive the vaccine were significantly more persuaded by the effectiveness of the vaccine and perceived less its side effects for elderly persons and those with chronic disease (p < 0.001).

Table 2 Knowledge and attitudes towards general statements about influenza and influenza vaccine stratified by vaccination intention
Full size table

Doctors were by far the most trusted source for information regarding influenza vaccine (91.5%). Only 2.9% of surveyed persons trusted the media as reliable source of information. No participants cited the internet as trusted source for influenza vaccine-related information. The two main reasons that may lead the elderly to accept influenza vaccination were a doctor’s recommendation (41.1%) and protection against contracting influenza (39.6%). The two main reasons that may lead to refusal of vaccination among the elderly were concerns that the vaccine could cause side effects (71.5%) and a belief that the vaccine could be ineffective (33.9%) (Table 3).

Table 3 Most trusted sources and top reasons for accepting and refusing to receive influenza vaccine
Full size table

In the bivariate analysis, willingness to receive influenza vaccine among the elderly was not significantly associated to socio-demographic factors. Participants with chronic pulmonary diseases were 2.2 times more likely to be willing to receive the influenza vaccine (p = 0.008), while surprisingly those with heart disease were less likely to accept vaccine (COR = 0.57 [0.43–0.73]). Persons who had knowledge about influenza, those who are aware about the existence of a vaccine and those who knew someone who was severely ill with influenza were significantly more willing to receive the influenza vaccine (COR = 1.95 [1.42–2.68], COR = 1.47 [1.11–1.94] and COR = 1.45 [1.08–1.94] respectively). Participants who estimated that they received enough information about the safety of influenza vaccine and vaccines in general showed higher willingness to receive the vaccine (COR = 2.29 [1.40–3.74] and COR = 5.62 [3.34–9.46] respectively). Receiving an influenza vaccine recommendation and trusting the advice of healthcare providers were positively associated with willingness to receive vaccine among elderly persons (COR = 4.11 [3.02–5.60] and COR = 7.60 [4.12–14.03] respectively). The odds of willing to receive influenza vaccine among vaccinated persons during the 2018–2019 influenza season were 45.3 times higher compared to unvaccinated ones (p < 0.001).

Multiple logistic regression analysis revealed that willingness to receive influenza vaccination was more likely among participants with chronic pulmonary disease (AOR = 2.63 [1.15–6.03]), those suffering from diabetes (AOR = 1.67 [1.05–2.65]), those who received the influenza vaccine during the 2018–2019 season (AOR = 16.53 [3.77–72.45]), those who felt they got enough information about vaccines and their safety (AOR = 2.91 [1.59–5.34]), and those who trusted the advice of their health care provider (AOR = 4.49 [2.19–9.24]).

Discussion

We examined the influenza vaccination rate among 1191 Tunisian elderly persons with chronic disease(s) during the 2018–2019 influenza season and factors influencing their intention to receive the vaccine. About one-fifth of participants were vaccinated during the 2018–2019 influenza season, while nearly two-thirds expressed willingness to receive influenza vaccination.

Vaccine uptake among the study population was 19.4%, far below the 75% recommended by the WHO. It is possible that the overall coverage of influenza vaccine uptake among the Tunisian older population (including healthy persons and those with underlying conditions) was lower than the rate found in our study population. In fact, the presence of comorbidities has been identified in several studies as a predictor of influenza vaccination in the elderly [15,16,17,18]. Older persons with chronic medical conditions may be more motivated to receive vaccination because they perceived themselves to be at higher risk for influenza complications [15, 19]. Moreover, health professionals tend to stress the importance of vaccination among this high-risk group [15, 17, 19].

The vaccine coverage estimated in our study was lower than that found among elderly in some member states in the Mediterranean region of the Organization for Economic Co-operation and Development (OECD), including Portugal (60.8%), Spain (50.7%), Italy (52.7%), France (49.7%), and Greece (48.9%) [20]. In contrast, the uptake in Tunisia was higher than that observed in Slovenia (11.8%) and Turkey (7.0%) [20]. Only Korea (82.7%) and Mexico (82.3%), two member states of the OECD, have reached the coverage recommended by the WHO [20]. In Africa, very little data is available regarding influenza vaccine uptake among the elderly, despite the sharp increase in the impact of influenza due to the burden of other diseases such as HIV/AIDS and tuberculosis [21]. A recent study among South African private health insurance scheme members showed that the vaccination uptake in persons older than 65 years was 18.5% [21]. Similarly, vaccine uptake rates reported in previous studies among patients with chronic conditions have varied. In a study conducted among patients with chronic diseases visiting an Italian out-patient clinic, Napolitano et al. found that nearly half of participants were vaccinated against influenza in 2018–2019 [22]. However, Ye et al. and Mohr et al., [23, 24] reported that only 7.8% of diabetic patients in china and less than 30% of patients with chronic pulmonary diseases in Germany received influenza vaccine respectively.

While the vaccination uptake rate was low among our study population, nearly two-thirds of participants expressed willingness to receive the influenza vaccine. Most previous studies examined factors associated with previous influenza vaccine uptake, but this study’s main interest was in the factors associated with willingness in regard to future vaccination. In fact, even if influenza vaccine uptake could be predictive of future uptake, receipt of vaccine may vary from season to season [7, 25,26,27]. According to Zimmerman et al. [28], intention was “the strongest predictor of behavior”, however the environment and the cues for action such as the medical advice are also strong motivators as shown in our study.

We found that willingness to receive influenza vaccine among the elderly was not influenced by socio-demographic factors. Compared to persons with other diseases, people suffering from chronic pulmonary disease and those with diabetes were more willing to be vaccinated, which is consistent with two previous studies that found older persons with pulmonary diseases are more likely to be vaccinated [29, 30]. These groups may have higher perceived severity when they contract the influenza virus, since it is a respiratory infection that could decompensate chronic pulmonary diseases or lead to severe acute respiratory distress when the infected is immunocompromised. There remains a need to improve knowledge about influenza vaccination in the older population and to inform elderly about chronic conditions that can increase the morbidity and mortality tolls of influenza. In agreement with previous studies, persons willing to receive influenza vaccine were more convinced of the danger of influenza for elderly persons and for persons with chronic diseases. They were also significantly more persuaded by the effectiveness of the vaccine, and perceived less its side effects for elderly persons compared to those who refused vaccination [16, 31]. In our study, reasons reported as discouraging the influenza vaccine uptake were, mainly concerns that the vaccine could cause side effects (71.5%) and beliefs of its ineffectiveness (33.9%). These findings, corroborates the conclusions of previous studies [2, 18]. It is important to correct misconceptions about adverse events and efficiency of the vaccine [1]. In fact, influenza vaccines are generally well tolerated and safe among elderly [6] and can even confer cross-protection when the circulating strains are not well matching the vaccine strains [32].

Our study is consistent with previous findings that demonstrated that willingness to be vaccinated was strongly associated with former vaccination status [23, 26, 28, 31, 33,34,35,36]. Indeed, positive experience with the vaccine may lead to perception of higher benefits and fewer barriers to vaccination [36], making those who received the vaccine more likely to be regularly compliant [33, 34]. In fact, once individuals have adopted a behavior, they are likely to change their beliefs to be in agreement with this behavior [37]. Thus, campaigns promoting influenza vaccination among the elderly may have a snowball effect, inducing a cumulative increase in vaccination rates every year [35].

The multivariate analysis showed that trusting the advice of heath care providers was significantly associated with willingness to receive vaccination among elderly persons. We found the main reason for accepting influenza vaccine was receiving a doctor’s recommendation (41.1%) as well. The most trusted sources for information about influenza vaccine were doctors (91.5%), followed by pharmacists (17.6%), and then other healthcare professionals (14.1%). These findings highlighted the important role that physicians could play in improving influenza vaccination uptake among elderly people with chronic disease(s). They are consistent with previous studies showing that recommendations from health care professionals are one of the strongest facilitators for influenza vaccination [1, 16, 23, 34]. Physicians in particular have a crucial role in educating their patients to adopt relevant attitudes and practices toward influenza vaccination [1]. Paradoxically, according to a systematic literature review, several studies reported that many physicians do not recommend the vaccine to their patients [34]. Potential explanations were that doctors cover a wide range of topics during consultations, underestimating the key influence vaccines can play, etc. [34, 35, 38]. A study conducted in Taiwan suggested that physicians give more importance to treatment than to prevention of diseases, and that some doctors may fear further burdening an already weakened immune system in older patients with chronic diseases [35]. This confirms the need to promote the comprehensive approach in the medical practice including, promotion, prevention and restauration of health. Our study advocates for targeting the health care professionals, who should be aware of their crucial role in promoting influenza vaccination among their patients as demonstrated elsewhere [39, 40].

Our study is one of the first on influenza vaccination among elderly with chronic diseases, in Tunisia. Our findings could be of great importance in the current context of COVID-19 pandemic since some factors influencing the attitudes of elderly people towards influenza vaccine could also determine their decisions regarding COVID-19 vaccination which is also recommended for this population group. This study had several limitations. First we did not include those who are seeking care at the university hospitals or in the private sector. These patients might have more severe stages of chronic diseases which might affect the generalizability of our findings, as their knowledge, attitudes, and practices may differ from those in our survey. Second, data about vaccine uptake were self-reported and not validated with medical records; therefore findings might be subject to recall biases [1, 7, 16,17,18, 31]. We believe that the exclusion of persons with even mild cognitive disorders reduces this potential bias. Unfortunately, medical validation of influenza vaccine uptake was not always possible. Third, as many elderly participants were illiterate we did not use a self-administered questionnaire, which may lead to a social desirability bias [33]. Finally, the cross-sectional design of our study did not allow for inferring causal relationships between dependent and independents variables [19, 26].

Conclusions

This study revealed a low coverage of influenza vaccine uptake among elderly with chronic diseases and identified the main barriers and predictors for influenza vaccination in Tunisia among this target group. Results further suggested that influenza vaccine promotion campaigns should involve more health care professionals. In fact, promoting a comprehensive practice of care including vaccination for all age groups among health care providers can increase the rate of influenza vaccine uptake through time. A training program on influenza and influenza vaccine might be a good strategy to encourage them promoting this preventive measure.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Abbreviations

AIDS:

Acquired Immunodeficiency Syndrome

AOR:

Adjusted Odds Ratio

COR:

Crude Odds Ratio

COVID-19:

Coronavirus Disease 2019

HIV:

Human Immunodeficiency Virus

OECD:

Organization for Economic Co-operation and Development

WHA:

World Health Assembly

WHO:

World Health Organization

References

  1. Bertoldo G, Pesce A, Pepe A, Pelullo CP, Di Giuseppe G, The Collaborative Working Group. Seasonal influenza: knowledge, attitude and vaccine uptake among adults with chronic conditions in Italy. PLoS One. 2019;14(5):e0215978.

    Article  Google Scholar 

  2. McIntyre A, Zecevic A, Diachun L. Influenza vaccinations: older adults’ decision-making process. Can J Aging. 2014;33(1):92–8.

    Article  Google Scholar 

  3. Kwong EW, Pang SM, Choi PP, Wong TK. Influenza vaccine preference and uptake among older people in nine countries. J Adv Nurs. 2010;66(10):2297–308.

    Article  Google Scholar 

  4. World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. Fifty-sixth world health assembly: resolution WHA56. 19. 2003. https://apps.who.int/iris/bitstream/handle/10665/78320/ea56r19.pdf?sequence=1&isAllowed=y. Accessed 14 Jan 2020.

    Google Scholar 

  5. World Health Organization. Influenza (seasonal). 2018. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 14 Jan 2020.

    Google Scholar 

  6. Smetana J, Chlibek R, Shaw J, Splino M, Prymula R. Influenza vaccination in the elderly. Hum Vaccin Immunother. 2018;14(3):540–9.

    Article  Google Scholar 

  7. Gazibara T, Kovacevic N, Kisic-Tepavcevic D, Nurkovic S, Kurtagic I, Gazibara T, et al. Flu vaccination among older persons: study of knowledge and practices. J Health Popul Nutr. 2019;38(1):2.

    Article  Google Scholar 

  8. Ciblak MA, Platformu G. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate. Vaccine. 2013;31(3):518–23.

    Article  Google Scholar 

  9. The Macroepidemiology of Influenza Vaccination (MIV) Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997–2003. Vaccine. 2005;23(44):5133–43.

    Article  Google Scholar 

  10. European Centre for Disease Prevention and Control. Vaccine hesitancy. https://www.ecdc.europa.eu/en/immunisation-vaccines/vaccine-hesitancy. Accessed 9 Oct 2021.

  11. Dubé E, Farrands A, Lemaitre T, Boulianne N, Sauvageau C, Boucher FD, et al. Overview of knowledge, attitudes, beliefs, vaccine hesitancy and vaccine acceptance among mothers of infants in Quebec, Canada. Hum Vaccin Immunother. 2019;15(1):113–20.

    Article  Google Scholar 

  12. Bianco A, Mascaro V, Zucco R, Pavia M. Parent perspectives on childhood vaccination: how to deal with vaccine hesitancy and refusal? Vaccine. 2019;37:984–90.

    Article  Google Scholar 

  13. Napolitano F, D’Alessandro A, Angelillo IF. Investigating Italian parents’ vaccine hesitancy: a cross-sectional survey. Hum Vaccin Immunother. 2018;14(7):1558–65.

    Article  Google Scholar 

  14. De Lataillade C, Auvergne S, Delannoy I. 2005 and 2006 seasonal influenza vaccination coverage rates in 10 countries in Africa, Asia Pacific, Europe, Latin America and the Middle East. J Public Health Policy. 2009;30(1):83–101.

    Article  Google Scholar 

  15. Ang L, Cutter J, James L, Goh K. Factors associated with influenza vaccine uptake in older adults living in the community in Singapore. Epidemiol Infect. 2017;145(4):775–86.

    Article  CAS  Google Scholar 

  16. Mo P, Lau J. Influenza vaccination uptake and associated factors among elderly population in Hong Kong: the application of the health belief model. Health Educ Res. 2015;30(5):706–18.

    Article  CAS  Google Scholar 

  17. Ryu SY, Kim SH, Park HS, Park J. Influenza vaccination among adults 65 years or older: a 2009–2010 community health survey in the Honam region of Korea. Int J Environ Res Public Health. 2011;8(11):4197–206.

    Article  Google Scholar 

  18. Kwong EWY, Lam IOY, Chan TMF. What factors affect influenza vaccine uptake among community-dwelling older Chinese people in Hong Kong general outpatient clinics? J Clin Nurs. 2009;18(7):960–71.

    Article  Google Scholar 

  19. Sato APS, Antunes JLF, Lima-Costa MFF, de Andrade FB. Influenza vaccine uptake among older adults in Brazil: socioeconomic equality and the role of preventive policies and public services. J Infect Public Health. 2020;13(2):211–5.

    Article  Google Scholar 

  20. Organization for Economic Co-operation and Development. Influenza vaccination rates. 2019. https://data.oecd.org/healthcare/influenza-vaccination-rates.htm. Accessed 26 Jan 2020.

    Google Scholar 

  21. Solanki G, Cornell M, Lalloo R. Uptake and cost of influenza vaccines in a private health insured south African population. S Afr J Infect Dis. 2018;33(5):1–4.

  22. Napolitano F, Della Polla G, Capano MS, Augimeri M, Angelillo IF. Vaccinations and chronic diseases: knowledge, attitudes, and self-reported adherence among patients in Italy. Vaccines. 2020;8:560.

    Article  Google Scholar 

  23. Ye L, Fang T, Cui J, Zhu G, Ma R, Sun Y. The intentions to get vaccinated against influenza and actual vaccine uptake among diabetic patients in Ningbo, China: identifying motivators and barriers. Hum Vaccin Immunother. 2021;17(1):106–18.

    Article  Google Scholar 

  24. Mohr A, Plentz A, Sieroslawski A, Pezenburg F, Pfeifer M, Salzberger B, et al. Use of pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany. Respir Med. 2020;174:106207.

    Article  Google Scholar 

  25. Holm MV, Blank PR, Szucs TD. Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis. 2007;7(1):144.

    Article  Google Scholar 

  26. Mangtani P, Breeze E, Stirling S, Hanciles S, Kovats S, Fletcher A. Cross-sectional survey of older peoples’ views related to influenza vaccine uptake. BMC Public Health. 2006;6(1):249.

    Article  Google Scholar 

  27. Wada K, Smith DR. Influenza vaccination uptake among the working age population of Japan: results from a national cross-sectional survey. PLoS One. 2013;8(3):e59272.

    Article  CAS  Google Scholar 

  28. Zimmerman RK, Santibanez TA, Janosky JE, Fine MJ, Raymund M, Wilson SA, et al. What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and Veterans Affairs practices. Am J Med. 2003;114(1):31–8.

    Article  Google Scholar 

  29. Moura RF, Andrade FB, Duarte YAO, Lebrão ML, Antunes JLF. Factors associated with adherence to influenza vaccination among non-institutionalized elderly in São Paulo, Brazil. Cad Saude Publica. 2015;31(10):1–11.

    Article  Google Scholar 

  30. Dannetun E, Tegnell A, Normann B, Garpenholt Ö, Giesecke J. Influenza vaccine coverage and reasons for non-vaccination in a sample of people above 65 years of age, in Sweden, 1998-2000. Scand J Infect Dis. 2003;35(6–7):389–93.

    Article  Google Scholar 

  31. Doris S, Low LP, Lee IF, Lee DT, Ng WM. Predicting influenza vaccination intent among at-risk Chinese older adults in Hong Kong. Nurs Res. 2014;63(4):270–7.

    Article  Google Scholar 

  32. Tan E, Lim L, Teoh Y, Ong G, Bock H. Influenza and seasonal influenza vaccination among diabetics in Singapore: knowledge, attitudes and practices. Singap Med J. 2010;51(8):623.

    CAS  Google Scholar 

  33. Ganczak M, Gil K, Korzeń M, Bażydło M. Coverage and influencing determinants of influenza vaccination in elderly patients in a country with a poor vaccination implementation. Int J Environ Res Public Health. 2017;14(6):665.

    Article  Google Scholar 

  34. Nagata JM, Hernández-Ramos I, Kurup AS, Albrecht D, Vivas-Torrealba C, Franco-Paredes C. Social determinants of health and seasonal influenza vaccination in adults≥ 65 years: a systematic review of qualitative and quantitative data. BMC Public Health. 2013;13(1):388.

    Article  Google Scholar 

  35. Li Y-C. Absence of influenza vaccination among high-risk older adults in Taiwan. BMC Public Health. 2010;10(1):603.

    Article  Google Scholar 

  36. Yu M-C, Chou Y-L, Lee P-L, Yang Y-C, Chen K-T. Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan. Hum Vaccin Immunother. 2014;10(4):1028–35.

    Article  Google Scholar 

  37. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health Educ Q. 1988;15(2):175–83.

    Article  CAS  Google Scholar 

  38. Brull R, Ghali WA, Quan H. Missed opportunities for prevention in general internal medicine. CMAJ. 1999;160(8):1137–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Dip RM, Cabrera MA. Influenza vaccination in non-institutionalized elderly: a population-based study in a medium-sized city in southern Brazil. Cad Saude Publica. 2010;26:1035–44.

    Article  Google Scholar 

  40. Humair J-P, Buchs CR, Stalder H. Promoting influenza vaccination of elderly patients in primary care. Fam Pract. 2002;19(4):383–9.

    Article  Google Scholar 

Download references

Acknowledgments

We thank Margaret McCarron and Kathryn Lafond from the US CDC and Malembe Ebama from the Task Force for Global Health for contributing to the study design and the regional health directorates of Ariana, Ben Arous, Bizerte, Gafsa, Kairouan, Mahdia, Siliana and Sousse for participating to data collection.

Language editing

This manuscript was edited by Elsevier Language Editing Services.

Funding

This project was funded by the Task Force for Global Health [grant numbers: F821E23E-52C0-4C51-8FC9-C356C34499B2].

Author information

Authors and Affiliations

  1. Laboratory of Medical Epidemiology, Pasteur Institute of Tunis, 13, Place Pasteur, B.P.74, 1002, Belvédère, Tunis, Tunisia

    Ghassen Kharroubi, Ines Cherif, Adel Gharbi, Aicha Boukthir, Afif Ben Salah & Jihene Bettaieb

  2. Laboratory of Transmission, Control and Immunobiology of Infections (LR11IPT02), Pasteur Institute of Tunis, Tunis, Tunisia

    Ghassen Kharroubi, Ines Cherif, Adel Gharbi, Aicha Boukthir, Afif Ben Salah & Jihene Bettaieb

  3. National Observatory of New and Emerging Diseases, Tunis, Tunisia

    Leila Bouabid & Nissaf Ben Alaya

  4. Department of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

    Afif Ben Salah

Authors
  1. Ghassen Kharroubi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ines Cherif
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leila Bouabid
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Adel Gharbi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aicha Boukthir
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nissaf Ben Alaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Afif Ben Salah
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jihene Bettaieb
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Ghassen Kharroubi: Conception of the work, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Ines Cherif: Conception of the work, Investigation, Methodology, Writing - original draft, Leila Bouabid: Data curation, Investigation, Project administration, Resources, Adel Gharbi: Data curation, Investigation, Project administration, Resources, Aicha Boukthir: Conception of the work Nissaf Ben Alaya: Conception of the work, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - review & editing, Afif Ben Salah: Conception of the work, Methodology, Resources, Funding acquisition, Supervision, Validation, Visualization, Writing - review & editing, Jihene Bettaieb: Conception of the work, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Visualization, Writing - review & editing. The author(s) read and approved the final manuscript.

Corresponding author

Correspondence to Jihene Bettaieb.

Ethics declarations

Ethics approval and consent to participate

All methods were carried out in accordance with relevant guidelines and regulations. Ethics approval was obtained from the Biomedical Ethics Committee of the Pasteur Institute of Tunis (Registration number: 2018/40/I/LR16IPT02). The study was approved by national and local health authorities. All participants were fully informed about the study and signed a written informed consent to be enrolled.

Consent for publication

Not applicable.

Competing interests

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Questionnaire.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kharroubi, G., Cherif, I., Bouabid, L. et al. Influenza vaccination knowledge, attitudes, and practices among Tunisian elderly with chronic diseases. BMC Geriatr 21, 700 (2021). https://doi.org/10.1186/s12877-021-02667-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12877-021-02667-z

Keywords

BMC Geriatrics

ISSN: 1471-2318

Contact us